Pacira BioSciences Inc (PCRX) Event Aug. 03, 2022, 00:00 UTC (51% Neutral) PACIRA BIOSCIENCES, INC. (PCRX) Reports Profit for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:43 a.m. 🏢 Pacira BioSciences Inc (PCRX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-03 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $29.45M $26.70M $2.75M +10.28% 📉 Total Assets $2.08B $1.73B $341.37M +19.69% 📈 Total Liabilities $1.34B $977.35M $367.59M +37.61% 📉 Stockholders' Equity $181.00K N/A $181.00K +0.00% ➡️ Operating Income/Loss $54.28M $48.63M $5.65M +11.62% 📉 R&D Expense $28.45M $47.89M $-19.43M -40.58% 📈 SG&A Expense $99.33M $129.26M $-29.93M -23.15% 📈 Earningspersharebasic $0.67 $0.59 $0.08 +13.56% 📈 Earningspersharediluted $0.64 $0.55 $0.09 +16.36% 📈 Costofrevenue $66.60M $86.70M $-20.10M -23.19% 📉 📈 Financial Trend Analysis 💰 Profitability improved with +10.3% net income growth • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Pacira BioSciences Inc (PCRX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
💰 Profitability improved with +10.3% net income growth • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document